DE60237671D1 - Implantierbare vorrichtung enthaltend resorbierbares matrixmaterial und antiproliferative wirkstoffe zur vorbeugung oder behandlung von versagen vaskulärer hämodialysezugänge und anderer vaskulärer transplantate - Google Patents
Implantierbare vorrichtung enthaltend resorbierbares matrixmaterial und antiproliferative wirkstoffe zur vorbeugung oder behandlung von versagen vaskulärer hämodialysezugänge und anderer vaskulärer transplantateInfo
- Publication number
- DE60237671D1 DE60237671D1 DE60237671T DE60237671T DE60237671D1 DE 60237671 D1 DE60237671 D1 DE 60237671D1 DE 60237671 T DE60237671 T DE 60237671T DE 60237671 T DE60237671 T DE 60237671T DE 60237671 D1 DE60237671 D1 DE 60237671D1
- Authority
- DE
- Germany
- Prior art keywords
- vascular
- hemodialysis
- accumulations
- preventing
- active substances
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/225—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
- A61M1/3655—Arterio-venous shunts or fistulae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
- A61M2039/0258—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body for vascular access, e.g. blood stream access
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/0247—Semi-permanent or permanent transcutaneous or percutaneous access sites to the inside of the body
- A61M2039/0261—Means for anchoring port to the body, or ports having a special shape or being made of a specific material to allow easy implantation/integration in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0468—Liquids non-physiological
- A61M2202/0478—Heparin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26213201P | 2001-01-16 | 2001-01-16 | |
PCT/US2002/001375 WO2002062335A2 (en) | 2001-01-16 | 2002-01-16 | Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60237671D1 true DE60237671D1 (de) | 2010-10-28 |
Family
ID=22996277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60237671T Expired - Lifetime DE60237671D1 (de) | 2001-01-16 | 2002-01-16 | Implantierbare vorrichtung enthaltend resorbierbares matrixmaterial und antiproliferative wirkstoffe zur vorbeugung oder behandlung von versagen vaskulärer hämodialysezugänge und anderer vaskulärer transplantate |
Country Status (18)
Country | Link |
---|---|
US (5) | US6726923B2 (de) |
EP (2) | EP1351681B1 (de) |
JP (2) | JP4584537B2 (de) |
CN (1) | CN1492759A (de) |
AP (1) | AP2003002828A0 (de) |
AT (1) | ATE481097T1 (de) |
AU (1) | AU2002249958B2 (de) |
BR (1) | BR0206464A (de) |
CA (1) | CA2434972C (de) |
CY (1) | CY1119109T1 (de) |
DE (1) | DE60237671D1 (de) |
DK (1) | DK2314293T3 (de) |
ES (1) | ES2621652T3 (de) |
MX (1) | MXPA03006315A (de) |
NZ (1) | NZ527046A (de) |
PT (1) | PT2314293T (de) |
RU (1) | RU2345719C2 (de) |
WO (1) | WO2002062335A2 (de) |
Families Citing this family (179)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7963997B2 (en) | 2002-07-19 | 2011-06-21 | Kensey Nash Corporation | Device for regeneration of articular cartilage and other tissue |
US8697108B2 (en) * | 1994-05-13 | 2014-04-15 | Kensey Nash Corporation | Method for making a porous polymeric material |
US8795242B2 (en) * | 1994-05-13 | 2014-08-05 | Kensey Nash Corporation | Resorbable polymeric device for localized drug delivery |
EP1616563A3 (de) * | 1996-05-24 | 2006-01-25 | Angiotech Pharmaceuticals, Inc. | Perivaskuläre Verabreichung anti-angiogener Faktoren zur Behandlung oder Prävention von Gefässerkrankungen |
US7959664B2 (en) * | 1996-12-26 | 2011-06-14 | Medinol, Ltd. | Flat process of drug coating for stents |
US7399480B2 (en) * | 1997-09-26 | 2008-07-15 | Abbott Laboratories | Methods of administering tetrazole-containing rapamycin analogs with other therapeutic substances using medical devices |
US6890546B2 (en) | 1998-09-24 | 2005-05-10 | Abbott Laboratories | Medical devices containing rapamycin analogs |
US20030129215A1 (en) * | 1998-09-24 | 2003-07-10 | T-Ram, Inc. | Medical devices containing rapamycin analogs |
US8257726B2 (en) * | 1997-09-26 | 2012-09-04 | Abbott Laboratories | Compositions, systems, kits, and methods of administering rapamycin analogs with paclitaxel using medical devices |
US8057816B2 (en) * | 1997-09-26 | 2011-11-15 | Abbott Laboratories | Compositions and methods of administering paclitaxel with other drugs using medical devices |
US20030040790A1 (en) * | 1998-04-15 | 2003-02-27 | Furst Joseph G. | Stent coating |
US20020099438A1 (en) | 1998-04-15 | 2002-07-25 | Furst Joseph G. | Irradiated stent coating |
US7967855B2 (en) * | 1998-07-27 | 2011-06-28 | Icon Interventional Systems, Inc. | Coated medical device |
US8070796B2 (en) | 1998-07-27 | 2011-12-06 | Icon Interventional Systems, Inc. | Thrombosis inhibiting graft |
US9522217B2 (en) | 2000-03-15 | 2016-12-20 | Orbusneich Medical, Inc. | Medical device with coating for capturing genetically-altered cells and methods for using same |
US8088060B2 (en) | 2000-03-15 | 2012-01-03 | Orbusneich Medical, Inc. | Progenitor endothelial cell capturing with a drug eluting implantable medical device |
DE60124285T3 (de) † | 2000-09-29 | 2011-03-17 | Cordis Corp., Miami Lakes | Beschichtete medizinische geräte |
US20050084514A1 (en) * | 2000-11-06 | 2005-04-21 | Afmedica, Inc. | Combination drug therapy for reducing scar tissue formation |
US6534693B2 (en) * | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
US20040241211A9 (en) * | 2000-11-06 | 2004-12-02 | Fischell Robert E. | Devices and methods for reducing scar tissue formation |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
US6808518B2 (en) * | 2001-09-28 | 2004-10-26 | Ethicon, Inc. | Methods and devices for treating diseased blood vessels |
US8740973B2 (en) * | 2001-10-26 | 2014-06-03 | Icon Medical Corp. | Polymer biodegradable medical device |
US20030163144A1 (en) * | 2002-02-28 | 2003-08-28 | Weadock Kevin S. | Sponge for creating an anastomosis between vessels |
JP4265888B2 (ja) * | 2002-06-12 | 2009-05-20 | 株式会社リコー | 画像形成装置 |
US7361368B2 (en) * | 2002-06-28 | 2008-04-22 | Advanced Cardiovascular Systems, Inc. | Device and method for combining a treatment agent and a gel |
EP1539032A2 (de) * | 2002-07-02 | 2005-06-15 | Polycord, Inc. | Polymerisierte und modifizierte rapamycine und ihre verwendung bei der beschichtung medizinischer prothesen |
WO2004004579A1 (en) * | 2002-07-09 | 2004-01-15 | Eva Corporation | Delivery apparatus for use during a surgical procedure and method of using the same |
US8016881B2 (en) * | 2002-07-31 | 2011-09-13 | Icon Interventional Systems, Inc. | Sutures and surgical staples for anastamoses, wound closures, and surgical closures |
US20050163821A1 (en) * | 2002-08-02 | 2005-07-28 | Hsing-Wen Sung | Drug-eluting Biodegradable Stent and Delivery Means |
US7438925B2 (en) * | 2002-08-26 | 2008-10-21 | Biovention Holdings Ltd. | Drug eluting coatings for medical implants |
WO2004022124A1 (en) * | 2002-09-06 | 2004-03-18 | Abbott Laboratories | Medical device having hydration inhibitor |
ES2428354T3 (es) | 2002-09-18 | 2013-11-07 | Trustees Of The University Of Pennsylvania | Rapamicina para usar en la inhibición o prevención de la neovascularización coroidea |
EP1542739B1 (de) * | 2002-09-26 | 2008-12-10 | Angiotech International Ag | Perivaskuläre hüllen |
AU2002953440A0 (en) * | 2002-12-19 | 2003-01-09 | Unisearch Limited | A method of treating a stiffened vessel |
US20050233030A1 (en) * | 2004-03-10 | 2005-10-20 | Broin And Associates, Inc. | Methods and systems for producing ethanol using raw starch and fractionation |
MXPA05009553A (es) * | 2003-03-10 | 2006-03-17 | Broin And Associates Inc | Metodo para producir etanol utilizando almidon como materia prima. |
EP1460088A1 (de) | 2003-03-21 | 2004-09-22 | Biotest AG | Humanisierter Antikörper gegen CD4 mit immunsuppressiven Merkmalen |
US8821473B2 (en) | 2003-04-15 | 2014-09-02 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
US8383158B2 (en) * | 2003-04-15 | 2013-02-26 | Abbott Cardiovascular Systems Inc. | Methods and compositions to treat myocardial conditions |
DK1638624T3 (da) * | 2003-06-19 | 2014-02-03 | Vascular Therapies Llc | Vaskulær lukkeindretning |
EP1682196A2 (de) * | 2003-11-10 | 2006-07-26 | Angiotech International Ag | Medizinische implantate und anti-narben-mittel |
US7553326B2 (en) * | 2003-11-24 | 2009-06-30 | Sweet Richard M | Method and apparatus for preventing dialysis graft intimal hyperplasia |
US7211108B2 (en) * | 2004-01-23 | 2007-05-01 | Icon Medical Corp. | Vascular grafts with amphiphilic block copolymer coatings |
US20050239181A1 (en) * | 2004-03-10 | 2005-10-27 | Broin And Associates, Inc. | Continuous process for producing ethanol using raw starch |
US8431145B2 (en) | 2004-03-19 | 2013-04-30 | Abbott Laboratories | Multiple drug delivery from a balloon and a prosthesis |
US20100030183A1 (en) * | 2004-03-19 | 2010-02-04 | Toner John L | Method of treating vascular disease at a bifurcated vessel using a coated balloon |
US20070027523A1 (en) * | 2004-03-19 | 2007-02-01 | Toner John L | Method of treating vascular disease at a bifurcated vessel using coated balloon |
ATE534424T1 (de) * | 2004-03-19 | 2011-12-15 | Abbott Lab | Mehrfache arzneiabgabe aus einem ballon und eine prothese |
US8000784B2 (en) * | 2004-04-19 | 2011-08-16 | The Invention Science Fund I, Llc | Lumen-traveling device |
KR100596218B1 (ko) * | 2004-06-10 | 2006-07-03 | (주)액세스 플러스 | 약물이 표면처리된 혈액투석환자의 동정맥 연결용 튜브 |
US20060009839A1 (en) * | 2004-07-12 | 2006-01-12 | Scimed Life Systems, Inc. | Composite vascular graft including bioactive agent coating and biodegradable sheath |
WO2006017275A1 (en) | 2004-07-13 | 2006-02-16 | The University Of Tennessee Research Foundation | Adhesive composition for carrying therapeutic agents as delivery vehicle on coatings applied to vascular grafts |
US11207457B2 (en) | 2004-08-27 | 2021-12-28 | Edwards Lifesciences Corporation | Device and method for establishing an artificial arterio-venous fistula |
WO2006026725A2 (en) | 2004-08-31 | 2006-03-09 | C.R. Bard, Inc. | Self-sealing ptfe graft with kink resistance |
US20060069426A1 (en) * | 2004-09-27 | 2006-03-30 | Weinberger Judah Z | Methods and devices for extravascular intervention |
US20060106406A1 (en) * | 2004-09-27 | 2006-05-18 | Judah Weinberger | Methods and devices for extravascular intervention |
US20060135966A1 (en) | 2004-11-15 | 2006-06-22 | Laurent Schaller | Catheter-based tissue remodeling devices and methods |
US7993738B2 (en) * | 2004-11-30 | 2011-08-09 | The Regents Of The University Of Michigan | Modified porous materials and method of forming the same |
US20080118561A1 (en) * | 2004-12-08 | 2008-05-22 | Helen Marie Nugent | Materials and Methods for Minimally-Invasive Administration of a Cell-Containing Flowable Composition |
WO2006062909A2 (en) * | 2004-12-08 | 2006-06-15 | Pervasis Therapeutics, Inc. | Methods and compositions for enhancing vascular access |
WO2006086750A1 (en) | 2005-02-09 | 2006-08-17 | Macusight, Inc. | Liquid formulations for treatment of diseases or conditions |
US7540995B2 (en) | 2005-03-03 | 2009-06-02 | Icon Medical Corp. | Process for forming an improved metal alloy stent |
US20060264914A1 (en) * | 2005-03-03 | 2006-11-23 | Icon Medical Corp. | Metal alloys for medical devices |
US8323333B2 (en) * | 2005-03-03 | 2012-12-04 | Icon Medical Corp. | Fragile structure protective coating |
US9107899B2 (en) | 2005-03-03 | 2015-08-18 | Icon Medical Corporation | Metal alloys for medical devices |
WO2006110197A2 (en) * | 2005-03-03 | 2006-10-19 | Icon Medical Corp. | Polymer biodegradable medical device |
JP5335244B2 (ja) * | 2005-03-03 | 2013-11-06 | アイコン メディカル コーポレーション | 改良された金属合金を用いた医療用部材 |
US20060201601A1 (en) * | 2005-03-03 | 2006-09-14 | Icon Interventional Systems, Inc. | Flexible markers |
WO2007032777A2 (en) * | 2005-03-23 | 2007-03-22 | Abbott Laboratories | Compositions and methods of administering rapamycin analogs using medical devices for long-term efficacy |
US9539410B2 (en) | 2005-04-19 | 2017-01-10 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating post-cardial infarction damage |
US8828433B2 (en) * | 2005-04-19 | 2014-09-09 | Advanced Cardiovascular Systems, Inc. | Hydrogel bioscaffoldings and biomedical device coatings |
US20080125745A1 (en) | 2005-04-19 | 2008-05-29 | Shubhayu Basu | Methods and compositions for treating post-cardial infarction damage |
EP1874919B1 (de) | 2005-04-21 | 2010-06-09 | Massachusetts Institute Of Technology | Materialien und verfahren zur änderung einer immunreaktion auf exogene und endogene immunogene, einschliesslich genidentischer und nicht-genidentischer zellen, gewebe oder organe |
US8333777B2 (en) | 2005-04-22 | 2012-12-18 | Benvenue Medical, Inc. | Catheter-based tissue remodeling devices and methods |
US20070037267A1 (en) * | 2005-05-02 | 2007-02-15 | Broin And Associates, Inc. | Methods and systems for producing ethanol using raw starch and fractionation |
US8002738B2 (en) * | 2005-05-17 | 2011-08-23 | Boston Scientific Scimed, Inc. | Self-adhering lesion formation apparatus and methods |
CA2611119A1 (en) * | 2005-06-08 | 2006-12-14 | C.R. Bard Inc. | Grafts and stents having inorganic bio-compatible calcium salt |
CA2610896C (en) | 2005-06-17 | 2014-07-08 | C.R. Bard, Inc. | Vascular graft with kink resistance after clamping |
CN102743792B (zh) * | 2005-06-21 | 2014-09-24 | 夏尔再生医学公司 | 用于增强血管通路的方法和组合物 |
JP5118042B2 (ja) * | 2005-09-06 | 2013-01-16 | シー・アール・バード・インコーポレーテッド | 薬物結晶を含有する移植用インプラント |
US7219021B2 (en) * | 2005-09-13 | 2007-05-15 | Honeywell International Inc. | Multiple wireless sensors for dialysis application |
US7919289B2 (en) * | 2005-10-10 | 2011-04-05 | Poet Research, Inc. | Methods and systems for producing ethanol using raw starch and selecting plant material |
JP5285426B2 (ja) * | 2005-10-14 | 2013-09-11 | アボット ラボラトリーズ | 医療デバイスを用いて、パクリタキセルとともにラパマイシン類似体を投与することについての組成物、システム、キット及び方法 |
JP5280852B2 (ja) | 2005-11-09 | 2013-09-04 | シー・アール・バード・インコーポレーテッド | 放射線不透過性マーカーを有する移植片及びステント植皮 |
US20080317814A1 (en) * | 2005-11-17 | 2008-12-25 | Access Plus Co., Ltd. | Tube for Connecting Marteriovenous and Interposition for Medical Operation |
US20100204783A1 (en) * | 2005-12-06 | 2010-08-12 | Helen Marie Nugent | Methods and compositions for enhancing vascular access |
BRPI0600275A (pt) * | 2006-01-03 | 2007-10-02 | Brz Biotecnologia Ltda | prótese coronária liberadora de composição medicamentosa para prevenção e tratamento da reestenose e processo de fabricação |
JP5528708B2 (ja) | 2006-02-09 | 2014-06-25 | 参天製薬株式会社 | 安定な製剤ならびにそれらを調製および使用する方法 |
US8828077B2 (en) * | 2006-03-15 | 2014-09-09 | Medinol Ltd. | Flat process of preparing drug eluting stents |
US8222271B2 (en) | 2006-03-23 | 2012-07-17 | Santen Pharmaceutical Co., Ltd. | Formulations and methods for vascular permeability-related diseases or conditions |
US20090024152A1 (en) * | 2007-07-17 | 2009-01-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Custom-fitted blood vessel sleeve |
US8551155B2 (en) * | 2006-06-16 | 2013-10-08 | The Invention Science Fund I, Llc | Stent customization system and method |
US8550344B2 (en) * | 2006-06-16 | 2013-10-08 | The Invention Science Fund I, Llc | Specialty stents with flow control features or the like |
US8095382B2 (en) * | 2006-06-16 | 2012-01-10 | The Invention Science Fund I, Llc | Methods and systems for specifying a blood vessel sleeve |
US20080133040A1 (en) * | 2006-06-16 | 2008-06-05 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Methods and systems for specifying a blood vessel sleeve |
US8147537B2 (en) * | 2006-06-16 | 2012-04-03 | The Invention Science Fund I, Llc | Rapid-prototyped custom-fitted blood vessel sleeve |
US8163003B2 (en) * | 2006-06-16 | 2012-04-24 | The Invention Science Fund I, Llc | Active blood vessel sleeve methods and systems |
US8478437B2 (en) | 2006-06-16 | 2013-07-02 | The Invention Science Fund I, Llc | Methods and systems for making a blood vessel sleeve |
US20080172073A1 (en) * | 2006-06-16 | 2008-07-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Active blood vessel sleeve |
US7818084B2 (en) * | 2006-06-16 | 2010-10-19 | The Invention Science Fund, I, LLC | Methods and systems for making a blood vessel sleeve |
US7722665B2 (en) * | 2006-07-07 | 2010-05-25 | Graft Technologies, Inc. | System and method for providing a graft in a vascular environment |
WO2008008291A2 (en) * | 2006-07-13 | 2008-01-17 | Icon Medical Corp. | Stent |
US20080039362A1 (en) * | 2006-08-09 | 2008-02-14 | Afmedica, Inc. | Combination drug therapy for reducing scar tissue formation |
US20080077070A1 (en) * | 2006-08-10 | 2008-03-27 | Kopia Gregory A | Arteriovenous shunt |
US9242005B1 (en) | 2006-08-21 | 2016-01-26 | Abbott Cardiovascular Systems Inc. | Pro-healing agent formulation compositions, methods and treatments |
US20080085293A1 (en) * | 2006-08-22 | 2008-04-10 | Jenchen Yang | Drug eluting stent and therapeutic methods using c-Jun N-terminal kinase inhibitor |
EP2065056B1 (de) * | 2006-08-29 | 2016-09-28 | FUJIFILM Corporation | Hydrophile matrix enthaltend einer schwer wasserlöslichen verbindung und herstellungsverfahren dafür |
EP2079575B1 (de) | 2006-10-12 | 2021-06-02 | C.R. Bard, Inc. | Herstellungsverfahren für gefässtransplantate mit mehreren kanälen |
AU2007317789B2 (en) * | 2006-11-07 | 2011-02-10 | Shire Regenerative Medicine, Inc. | Materials and methods for treating and managing angiogenesis-mediated diseases |
US8741326B2 (en) * | 2006-11-17 | 2014-06-03 | Abbott Cardiovascular Systems Inc. | Modified two-component gelation systems, methods of use and methods of manufacture |
US9005672B2 (en) * | 2006-11-17 | 2015-04-14 | Abbott Cardiovascular Systems Inc. | Methods of modifying myocardial infarction expansion |
US8192760B2 (en) | 2006-12-04 | 2012-06-05 | Abbott Cardiovascular Systems Inc. | Methods and compositions for treating tissue using silk proteins |
US8177798B2 (en) | 2006-12-05 | 2012-05-15 | Tyco Healthcare Group Lp | Adhesive coated stent and insertion instrument |
US20100185156A1 (en) * | 2007-06-13 | 2010-07-22 | Pervasis Therapeutics, Inc. | Methods and Devices for Minimally-Invasive Delivery of Cell-Containing Flowable Compositions |
US8361092B1 (en) | 2007-06-18 | 2013-01-29 | Wilson T. Asfora | Vascular anastomosis device and method |
US10004507B2 (en) | 2007-06-18 | 2018-06-26 | Asfora Ip, Llc | Vascular anastomosis device and method |
US9504469B2 (en) | 2007-06-18 | 2016-11-29 | Asfora Ip, Llc | Vascular anastomosis device and method |
US8721711B2 (en) * | 2007-06-20 | 2014-05-13 | Oregon Health & Science University | Graft having microporous membrane for uniform fluid infusion |
WO2009073782A2 (en) * | 2007-12-04 | 2009-06-11 | Ams Research Corporation | Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue |
CA2746807A1 (en) * | 2007-12-14 | 2009-06-25 | Oregon Health & Science University | Drug delivery cuff |
AU2009214629A1 (en) * | 2008-02-13 | 2009-08-20 | Eric T. Choi | BMP-7 for use in treating vascular sclerosis |
CN102105185A (zh) * | 2008-02-26 | 2011-06-22 | 大卫·张 | 用于血管通路的方法和装置 |
PL2262838T3 (pl) | 2008-03-13 | 2016-10-31 | Środek do leczenia choroby | |
CA2717812A1 (en) | 2008-03-13 | 2009-09-17 | Biotest Ag | Agent for treating disease |
SG190598A1 (en) | 2008-03-13 | 2013-06-28 | Biotest Ag | Agent for treating disease |
US20090264906A1 (en) * | 2008-04-22 | 2009-10-22 | Medtronic Vascular, Inc. | Cuff Device |
DK2341937T3 (en) * | 2008-09-29 | 2015-02-09 | Biotest Ag | Composition for the treatment of a disease |
KR101034654B1 (ko) | 2009-01-15 | 2011-05-16 | 성균관대학교산학협력단 | 바이오액티브 물질 코팅방법 |
EP2896700B1 (de) | 2009-03-03 | 2017-08-02 | POET Research, Inc. | Fermentationssystem zur Herstellung von Ethanol aus Xylose |
WO2010102060A2 (en) * | 2009-03-03 | 2010-09-10 | Poet Research, Inc. | System for pre-treatment of biomass for the production of ethanol |
US8450094B1 (en) | 2009-03-03 | 2013-05-28 | Poet Research, Inc. | System for management of yeast to facilitate the production of ethanol |
US9068206B1 (en) | 2009-03-03 | 2015-06-30 | Poet Research, Inc. | System for treatment of biomass to facilitate the production of ethanol |
US20100233266A1 (en) | 2009-03-13 | 2010-09-16 | Cleek Robert L | Articles and methods of treating vascular conditions |
AU2010239605B2 (en) * | 2009-04-20 | 2014-06-26 | Rox Medical, Inc. | Device and method for establishing an artificial arterio-venous fistula |
WO2011006067A1 (en) * | 2009-07-09 | 2011-01-13 | Ams Research Corporation | Apparatus and methods of treatment of pathologic proliferative conditions uterine tissue |
JP2011528608A (ja) * | 2009-09-29 | 2011-11-24 | エム. アイ. テック カンパニー, インコーポレイテッド | 移植用チューブおよびそのコーティング方法 |
US10016460B2 (en) | 2009-11-27 | 2018-07-10 | Stephen Anthony Livesey | Method of inducing cellular growth and materials for use therewith |
GB0920944D0 (en) | 2009-11-30 | 2010-01-13 | Biotest Ag | Agents for treating disease |
US20110144577A1 (en) * | 2009-12-11 | 2011-06-16 | John Stankus | Hydrophilic coatings with tunable composition for drug coated balloon |
US8480620B2 (en) * | 2009-12-11 | 2013-07-09 | Abbott Cardiovascular Systems Inc. | Coatings with tunable solubility profile for drug-coated balloon |
US8951595B2 (en) * | 2009-12-11 | 2015-02-10 | Abbott Cardiovascular Systems Inc. | Coatings with tunable molecular architecture for drug-coated balloon |
US8900603B2 (en) | 2009-12-18 | 2014-12-02 | Interface Biologics, Inc. | Local delivery of drugs from self assembled coatings |
JP2011130989A (ja) * | 2009-12-25 | 2011-07-07 | Japan Health Science Foundation | 抗血栓性修飾剤、医療用具、及び、多孔質コラーゲン |
EP2603274B1 (de) | 2009-12-30 | 2020-12-16 | Caliber Therapeutics LLC | Ballonkathetersysteme zur freisetzung von trockenwirkstofffreisetzungsvesikeln in einem gefäss des körpers |
US8399044B2 (en) * | 2010-01-21 | 2013-03-19 | Snu R And Db Foundation | Method for coating medication on medical article |
EP2528537A4 (de) * | 2010-01-27 | 2016-09-07 | Vascular Therapies Inc | Vorrichtung und verfahren zur stenose-verhinderung an einer anastomose-stelle |
US8974519B2 (en) | 2010-02-19 | 2015-03-10 | Cardiovascular Systems, Inc. | Therapeutic agent delivery system, device and method for localized application of therapeutic substances to a biological conduit |
US8398916B2 (en) | 2010-03-04 | 2013-03-19 | Icon Medical Corp. | Method for forming a tubular medical device |
EP2544623B1 (de) * | 2010-03-09 | 2018-01-10 | Solinas Medical Inc. | Selbstschliessende vorrichtung |
IT1400232B1 (it) * | 2010-05-07 | 2013-05-24 | Advance Holdings Ltd | Composizione farmaceutica topica comprendente eparina |
CN109288789A (zh) | 2011-04-28 | 2019-02-01 | 阿布拉科斯生物科学有限公司 | 纳米颗粒组合物的血管内递送及其应用 |
US10350431B2 (en) * | 2011-04-28 | 2019-07-16 | Gt Medical Technologies, Inc. | Customizable radioactive carriers and loading system |
US20140186310A1 (en) * | 2011-05-26 | 2014-07-03 | Kathy Traianedes | Method of ex vivo cellular growth |
US8577693B2 (en) | 2011-07-13 | 2013-11-05 | The Invention Science Fund I, Llc | Specialty stents with flow control features or the like |
US9433722B2 (en) * | 2011-08-09 | 2016-09-06 | Abbott Cardiovascular Systems Inc. | Vascular shield and delivery system |
NO2802624T3 (de) * | 2012-01-09 | 2017-12-30 | ||
US20130303983A1 (en) * | 2012-05-09 | 2013-11-14 | Cook Medical Technologies Llc | Coated medical devices including a water-insoluble therapeutic agent |
EP2912121B1 (de) | 2012-10-29 | 2019-09-25 | Ariste Medical, LLC | Polymerbeschichtungszusammensetzungen und beschichtete gegenstände |
WO2014127278A2 (en) * | 2013-02-18 | 2014-08-21 | Elutin, Inc. | Site specific drug delivery wraps, systems and methods of use thereof |
US9492683B2 (en) | 2013-03-15 | 2016-11-15 | Gammatile Llc | Dosimetrically customizable brachytherapy carriers and methods thereof in the treatment of tumors |
US20150119908A1 (en) * | 2013-10-25 | 2015-04-30 | Abbott Cardiovascular Systems Inc. | Extravascular devices supporting an arteriovenous fistula |
US20150119976A1 (en) * | 2013-10-29 | 2015-04-30 | Abbott Cardiovascular Systems Inc. | Extravascular device for limiting blood flow adjacent an arteriovenous fistula |
US9687239B2 (en) | 2014-04-15 | 2017-06-27 | Abbott Cardiovascular Systems Inc. | Intravascular devices supporting an arteriovenous fistula |
GB2537770B (en) | 2014-04-22 | 2017-09-13 | Ariste Medical Llc | Methods and processes for application of drug delivery polymeric coatings |
BR112016030273A8 (pt) | 2014-06-24 | 2021-05-18 | Icon Medical Corp | dispositivo médico e método para formar o referido dispositivo |
US20160193390A1 (en) * | 2015-01-05 | 2016-07-07 | Wisconsin Alumni Research Foundation | Perivascular Delivery System And Method |
EP3250277B1 (de) * | 2015-01-26 | 2022-09-21 | Mercator Medsystems, Inc. | Verfahren und systeme zur verhinderung von gefässentzündungen |
US9821174B1 (en) | 2015-02-06 | 2017-11-21 | Gammatile Llc | Radioactive implant planning system and placement guide system |
US9907680B2 (en) * | 2015-04-10 | 2018-03-06 | Cook Medical Technologies Llc | Sliding fenestration |
US11766506B2 (en) | 2016-03-04 | 2023-09-26 | Mirus Llc | Stent device for spinal fusion |
US10888710B1 (en) | 2016-11-29 | 2021-01-12 | Gt Medical Technologies, Inc. | Transparent loading apparatus |
WO2019222843A1 (en) | 2018-05-22 | 2019-11-28 | Interface Biologics, Inc. | Compositions and methods for delivering drugs to a vessel wall |
DE102018127200B3 (de) * | 2018-10-31 | 2019-07-25 | Andreas Haas | Implantat zum subkutanen implantieren |
CN111012409A (zh) * | 2019-12-03 | 2020-04-17 | 王超 | 颞浅动脉额支与脑动脉皮层血运重建辅助三通及使用方法 |
CN114259607B (zh) * | 2021-12-28 | 2023-01-24 | 宇航 | 一种支架制备方法 |
WO2024068159A1 (en) | 2022-09-30 | 2024-04-04 | Biotronik Ag | Synthesis and characterization of cyclic hydrocarbon esters of everolimus |
WO2024068153A1 (en) | 2022-09-30 | 2024-04-04 | Biotronik Ag | Macrocyclic triene immunosuppressive compounds for perivascular medical treatment of vascular access fistulas, grafts and other vascular conditions |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU471719A3 (ru) | 1969-07-19 | 1975-05-25 | Шеринг Аг (Фирма) | Способ получени нитрофуриламиноалкоксипиримидина |
US3797485A (en) | 1971-03-26 | 1974-03-19 | Alza Corp | Novel drug delivery device for administering drug into blood circulation in blood vessel |
US4391797A (en) | 1977-01-05 | 1983-07-05 | The Children's Hospital Medical Center | Systems for the controlled release of macromolecules |
US4164559A (en) | 1977-09-21 | 1979-08-14 | Cornell Research Foundation, Inc. | Collagen drug delivery device |
US4409332A (en) | 1982-01-12 | 1983-10-11 | Jefferies Steven R | Collagen-enzyme conjugates that exhibit no inflammatory response and method for making the same |
US4677120A (en) | 1985-07-31 | 1987-06-30 | Molecular Design International | Topical prodrugs for treatment of acne and skin diseases |
US4863457A (en) | 1986-11-24 | 1989-09-05 | Lee David A | Drug delivery device |
US4889842A (en) | 1987-03-03 | 1989-12-26 | Morris Randall E | Concanavalin A dimers as therapeutic agents |
US4994491A (en) | 1988-12-14 | 1991-02-19 | Molecular Design International | Dermal uses of trans-retinoids for the treatment of cancer |
US4885311A (en) | 1987-06-29 | 1989-12-05 | Molecular Design International | Topical transretinoids for treatment of acne and skin diseases |
US5124356A (en) | 1987-06-29 | 1992-06-23 | Molecular Design International, Inc. | Dermal uses of trans-retinoids for the treatment of photoaging |
US4840940A (en) | 1987-10-21 | 1989-06-20 | Sottiurai Vikrom S | Method for reducing the occurrence of distal anastomotic intimal hyperplasia using fractionated heparin |
US5157049A (en) | 1988-03-07 | 1992-10-20 | The United States Of America As Represented By The Department Of Health & Human Services | Method of treating cancers sensitive to treatment with water soluble derivatives of taxol |
US5100668A (en) | 1988-06-14 | 1992-03-31 | Massachusetts Institute Of Technology | Controlled release systems containing heparin and growth factors |
US5074869A (en) * | 1988-09-26 | 1991-12-24 | Daicoff George R | Vascular occlusion device |
US5049584A (en) | 1988-12-14 | 1991-09-17 | Molecular Design International | Dermal uses of cis-retinoids for the treatment of cancer |
US5223269A (en) | 1989-08-31 | 1993-06-29 | Andrejs Liepins | Methods and composition for the treatment of hypertension |
US6326017B1 (en) | 1989-10-02 | 2001-12-04 | University Of Washington | Methods for the localized delivery of agents to blood vessels |
US5527532A (en) | 1989-11-13 | 1996-06-18 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
AU6747790A (en) | 1989-11-13 | 1991-06-13 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
US5540928A (en) | 1991-02-27 | 1996-07-30 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
US5138051A (en) | 1991-08-07 | 1992-08-11 | American Home Products Corporation | Rapamycin analogs as immunosuppressants and antifungals |
CA2082411A1 (en) | 1991-06-28 | 1992-12-29 | Robert D. Rosenberg | Localized oligonucleotide therapy |
US5169851A (en) | 1991-08-07 | 1992-12-08 | American Home Products Corporation | Rapamycin analog as immunosuppressants and antifungals |
US5202332A (en) | 1991-08-07 | 1993-04-13 | American Home Products Corporation | Rapamycin analog as immunosuppressant |
US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
AU669338B2 (en) | 1991-10-25 | 1996-06-06 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting |
US5516781A (en) | 1992-01-09 | 1996-05-14 | American Home Products Corporation | Method of treating restenosis with rapamycin |
IT1254915B (it) * | 1992-04-24 | 1995-10-11 | Gloria Cristalli | Derivati di adenosina ad attivita' a2 agonista |
US5288711A (en) | 1992-04-28 | 1994-02-22 | American Home Products Corporation | Method of treating hyperproliferative vascular disease |
WO1993023013A1 (en) * | 1992-05-20 | 1993-11-25 | New England Deaconess Hospital | Extravascular system for infusion of soluble substances |
US5283257A (en) | 1992-07-10 | 1994-02-01 | The Board Of Trustees Of The Leland Stanford Junior University | Method of treating hyperproliferative vascular disease |
CA2086874E (en) | 1992-08-03 | 2000-01-04 | Renzo Mauro Canetta | Methods for administration of taxol |
US6306421B1 (en) | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5480988A (en) * | 1992-10-13 | 1996-01-02 | American Home Products Corporation | Carbamates of rapamycin |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
CA2092271C (en) | 1993-03-09 | 2009-10-13 | Eddie Reed | Use of g-csf for treating taxol side-effects |
US5703247A (en) | 1993-03-11 | 1997-12-30 | Virginia Tech Intellectual Properties, Inc. | 2-Debenzoyl-2-acyl taxol derivatives and methods for making same |
US5571800A (en) | 1993-05-17 | 1996-11-05 | Azura, Inc. | Method for inhibiting allograft rejection by the administration of 6-azauridine or its triacetate derivative |
SI0703909T1 (en) | 1993-06-11 | 2000-08-31 | Pharmacia & Upjohn Company | Delta 6,7 -taxols antineoplastic use and pharmaceutical compositions containing them |
US5994341A (en) | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
EP0711158B2 (de) | 1993-07-29 | 2008-07-23 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Verfahren zur behandlung atherosklerose oder restenose mit hilfe eines mikrotubulusstabilisators |
US6323184B1 (en) | 1993-10-15 | 2001-11-27 | Thomas Jefferson University | Arteriovenous and venous graft treatments: methods and compositions |
US5519042A (en) | 1994-01-13 | 1996-05-21 | Hoechst Aktiengesellschaft | Method of treating hyperproliferative vascular disease |
IL112412A (en) | 1994-01-28 | 2000-02-29 | Upjohn Co | Delta 12,13-iso-taxol analogs and antineoplastic pharmaceutical compositions containing them |
DE69524501T2 (de) | 1994-08-12 | 2002-05-29 | Meadox Medicals Inc | Mit einen Heparin enhaltendes Kollagendichtmittel imprägniertes Gefässtransplantat |
US5660873A (en) | 1994-09-09 | 1997-08-26 | Bioseal, Limited Liability Corporaton | Coating intraluminal stents |
US5616680A (en) * | 1994-10-04 | 1997-04-01 | Hoechst Celanese Corporation | Process for producing liquid crystal polymer |
US5837728A (en) | 1995-01-27 | 1998-11-17 | Molecular Design International | 9-cis retinoic acid esters and amides and uses thereof |
US5766584A (en) | 1995-06-02 | 1998-06-16 | Massachusetts Institute Of Technology | Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells |
AU716005B2 (en) | 1995-06-07 | 2000-02-17 | Cook Medical Technologies Llc | Implantable medical device |
US5780653A (en) | 1995-06-07 | 1998-07-14 | Vivorx Pharmaceuticals, Inc. | Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers |
US6136961A (en) | 1995-09-11 | 2000-10-24 | Enzymed, Inc. | Biocatalytic methods for synthesizing and identifying biologically active compounds |
US5795286A (en) * | 1996-08-15 | 1998-08-18 | Cathco, Inc. | Radioisotope impregnated sheet of biocompatible material for preventing scar tissue formation |
ES2208974T3 (es) | 1996-08-23 | 2004-06-16 | Cook Biotech, Inc. | Protesis de injertos, materiales y metodos. |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6090996A (en) | 1997-08-04 | 2000-07-18 | Collagen Matrix, Inc. | Implant matrix |
US6015815A (en) | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
US6117166A (en) | 1997-10-27 | 2000-09-12 | Winston; Thomas R. | Apparatus and methods for grafting blood vessel tissue |
US6224794B1 (en) | 1998-05-06 | 2001-05-01 | Angiotech Pharmaceuticals, Inc. | Methods for microsphere production |
US6091980A (en) | 1998-05-12 | 2000-07-18 | Massachusetts Institute Of Technology | Stent slip sensing system and method |
US6179858B1 (en) | 1998-05-12 | 2001-01-30 | Massachusetts Institute Of Technology | Stent expansion and apposition sensing |
CN1338943A (zh) * | 1998-10-26 | 2002-03-06 | 路德维格癌症研究院 | 利用vegf-c或vegf-d基因或蛋白预防再狭窄 |
DE19849589C1 (de) | 1998-10-27 | 2000-06-15 | Glatt Process Technology Gmbh | Fibrin-Gewebekleber-Formulierung und Verfahren zu dessen Herstellung |
US6333347B1 (en) | 1999-01-29 | 2001-12-25 | Angiotech Pharmaceuticals & Advanced Research Tech | Intrapericardial delivery of anti-microtubule agents |
US6391333B1 (en) | 1999-04-14 | 2002-05-21 | Collagen Matrix, Inc. | Oriented biopolymeric membrane |
US6328762B1 (en) | 1999-04-27 | 2001-12-11 | Sulzer Biologics, Inc. | Prosthetic grafts |
JP2003520830A (ja) | 2000-01-25 | 2003-07-08 | エドワーズ ライフサイエンシーズ コーポレイション | 再狭窄および吻合内膜過形成処置のための送達系 |
US6746773B2 (en) | 2000-09-29 | 2004-06-08 | Ethicon, Inc. | Coatings for medical devices |
US6534693B2 (en) * | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
PE20091074A1 (es) | 2007-12-13 | 2009-07-26 | Bayer Healthcare Ag | Triazolotriazinas y triazolopirazinas y su uso |
-
2002
- 2002-01-16 AP APAP/P/2003/002828A patent/AP2003002828A0/en unknown
- 2002-01-16 US US10/051,708 patent/US6726923B2/en not_active Expired - Lifetime
- 2002-01-16 ES ES10176383.7T patent/ES2621652T3/es not_active Expired - Lifetime
- 2002-01-16 WO PCT/US2002/001375 patent/WO2002062335A2/en active IP Right Grant
- 2002-01-16 DE DE60237671T patent/DE60237671D1/de not_active Expired - Lifetime
- 2002-01-16 MX MXPA03006315A patent/MXPA03006315A/es active IP Right Grant
- 2002-01-16 NZ NZ527046A patent/NZ527046A/en not_active IP Right Cessation
- 2002-01-16 CA CA2434972A patent/CA2434972C/en not_active Expired - Lifetime
- 2002-01-16 RU RU2003125357/14A patent/RU2345719C2/ru not_active IP Right Cessation
- 2002-01-16 EP EP02718844A patent/EP1351681B1/de not_active Expired - Lifetime
- 2002-01-16 AU AU2002249958A patent/AU2002249958B2/en not_active Ceased
- 2002-01-16 JP JP2002562342A patent/JP4584537B2/ja not_active Expired - Fee Related
- 2002-01-16 BR BR0206464-2A patent/BR0206464A/pt not_active Application Discontinuation
- 2002-01-16 CN CNA02805296XA patent/CN1492759A/zh active Pending
- 2002-01-16 PT PT101763837T patent/PT2314293T/pt unknown
- 2002-01-16 DK DK10176383.7T patent/DK2314293T3/en active
- 2002-01-16 EP EP10176383.7A patent/EP2314293B1/de not_active Expired - Lifetime
- 2002-01-16 AT AT02718844T patent/ATE481097T1/de not_active IP Right Cessation
-
2004
- 2004-04-26 US US10/832,048 patent/US7807191B2/en active Active
-
2007
- 2007-10-31 US US11/931,143 patent/US8858982B2/en active Active
-
2008
- 2008-10-28 JP JP2008277246A patent/JP5748389B2/ja not_active Expired - Fee Related
-
2014
- 2014-10-08 US US14/509,279 patent/US10272073B2/en not_active Expired - Fee Related
-
2017
- 2017-04-04 CY CY20171100399T patent/CY1119109T1/el unknown
-
2019
- 2019-03-08 US US16/297,006 patent/US20190201383A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60237671D1 (de) | Implantierbare vorrichtung enthaltend resorbierbares matrixmaterial und antiproliferative wirkstoffe zur vorbeugung oder behandlung von versagen vaskulärer hämodialysezugänge und anderer vaskulärer transplantate | |
ATE349428T1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
DE69832838D1 (de) | Vorrichtung zur Aufbewahrung und/oder Behandlung von Chemikalien | |
DE69332732D1 (de) | Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose | |
DE60027894D1 (de) | Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen | |
ATE229502T1 (de) | Arylsulfonamide und analoga und ihre verwendung zur behandlung von neurodegenerativen erkrankungen | |
DE60109589D1 (de) | Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne | |
ATE255888T1 (de) | Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE60010456D1 (de) | Pharmazeutische oder diätetische zusammensetzung zur prävention oder behandlung von hyperoxalurie | |
DE59410094D1 (de) | Vorrichtung zur behandlung von biologischem gewebe und körperkonkrementen | |
DE69929996D1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
DE60140377D1 (de) | Mch antagonisten und deren verwendung zur behandlung von fettleibigkeit | |
DE60324777D1 (de) | Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten | |
ATA11989A (de) | Mittel zur vorbeugung gegen und behandlung von parodontopathien | |
DE60027429D1 (de) | Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien | |
DE69912670D1 (de) | Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen | |
DE69625883D1 (de) | Zusammensetzung zur Reinigung und/oder Desinfektion von medizinischen Geräten | |
DE69825319D1 (de) | Präparat zur vorbeugung und behandlung von entzündungen | |
DE69939075D1 (de) | Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten | |
DE69832722D1 (de) | L-threonat-eisen, pharmazeutische zusammensetzung und verwendung zur verbesserung und behandlung von anämie bei menschen | |
DE29812309U1 (de) | Implantat und Vorrichtung zur Behandlung von Implantaten | |
DE1083796T1 (de) | Vorbeugende und heilende verfahren und zusammensetzungen zur biologischen kontrolle des verderbs von erntegut | |
ATE193450T1 (de) | Pharmazeutische zusammensetzung zur vorbeugung oder behandlung von knochenbrüchen | |
DE602004017613D1 (de) | Pharmazeutische zusammensetzungen mit ascorbinsäure zur behandlung von pilz-superinfektionen und pilz-rezidiven |